Order Article Reprints

Shin S-H, Park M-H, Byeon J-J, Lee BI, Park Y, Ko A-r, Seong M-r, Lee S, Kim MR, Seo J, et al. A Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse. Pharmaceutics. 2018; 10(2):69. https://doi.org/10.3390/pharmaceutics10020069

Shin, Seok-Ho, Min-Ho Park, Jin-Ju Byeon, Byeong Ill Lee, Yuri Park, Ah-ra Ko, Mi-ran Seong, Soyeon Lee, Mi Ra Kim, Jinwook Seo, and et al. 2018. "A Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse" Pharmaceutics 10, no. 2: 69. https://doi.org/10.3390/pharmaceutics10020069

Shin, S.-H., Park, M.-H., Byeon, J.-J., Lee, B. I., Park, Y., Ko, A.-r., Seong, M.-r., Lee, S., Kim, M. R., Seo, J., Jung, M. E., Jin, D.-K., & Shin, Y. G. (2018). A Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse. Pharmaceutics, 10(2), 69. https://doi.org/10.3390/pharmaceutics10020069